University Department of Neurosurgery, Box 167, Level 4, A-Block, Addenbrooke's Hospital, Hills Road, Cambridge CB20QQ, UK.
Stroke. 2010 Jan;41(1):122-8. doi: 10.1161/STROKEAHA.109.560698. Epub 2009 Nov 12.
Delayed cerebral ischemia and infarction due to reduced CBF remains the leading cause of poor outcome after aneurysmal subarachnoid hemorrhage. Hypertonic saline (HS) is associated with an increase in CBF. This study explores whether CBF enhancement with HS in patients with poor-grade subarachnoid hemorrhage is associated with improved cerebral tissue oxygenation.
Continuous monitoring of arterial blood pressure, intracranial pressure, cerebral perfusion pressure, brain tissue oxygen, carbon dioxide, pH, and middle cerebral artery flow velocity was performed in 44 patients. Patients were given an infusion (2 mL/kg) of 23.5% HS. In 16 patients, xenon CT scanning was also performed. CBF in a region surrounding the tissue oxygen sensor was calculated. Data are mean+/-SD.
Thirty minutes postinfusion, a significant increase in arterial blood pressure, cerebral perfusion pressure, flow velocity, brain tissue pH, and brain tissue oxygen was seen together with a decrease in intracranial pressure (P<0.05). Intracranial pressure remained reduced for >300 minutes and flow velocity elevated for >240 minutes. A significant increase in brain tissue oxygen persisted for 240 minutes. Average baseline regional CBF was 33.9+/-13.5 mL/100 g/min, rising by 20.3%+/-37.4% (P<0.05) after HS. Patients with favorable outcome responded better to HS in terms of increased CBF, brain tissue oxygen, and pH and reduced intracranial pressure compared with those with an unfavorable outcome. A sustained increase in brain tissue oxygen (beyond 210 minutes) was associated with favorable outcome (P<0.023).
HS augments CBF in patients with poor-grade subarachnoid hemorrhage and significantly improves cerebral oxygenation for 4 hours postinfusion. Favorable outcome is associated with an improvement in brain tissue oxygen beyond 210 minutes.
由于 CBF 减少导致的迟发性脑缺血和梗死仍然是蛛网膜下腔出血后不良预后的主要原因。高渗盐水(HS)与 CBF 的增加有关。本研究探讨了在低分级蛛网膜下腔出血患者中使用 HS 增强 CBF 是否与改善脑氧合有关。
对 44 例患者进行连续监测动脉血压、颅内压、脑灌注压、脑氧、二氧化碳、pH 值和大脑中动脉血流速度。患者给予 23.5% HS 输注(2 毫升/公斤)。在 16 例患者中,还进行了氙 CT 扫描。计算围绕组织氧传感器的区域 CBF。数据为平均值+/-标准差。
输注后 30 分钟,动脉血压、脑灌注压、血流速度、脑 pH 值和脑氧明显增加,颅内压降低(P<0.05)。颅内压持续降低>300 分钟,血流速度升高>240 分钟。脑氧明显升高持续 240 分钟。平均基线区域 CBF 为 33.9+/-13.5 毫升/100 克/分钟,HS 后增加 20.3%+/-37.4%(P<0.05)。与预后不良的患者相比,预后良好的患者在 CBF、脑氧和 pH 值增加以及颅内压降低方面对 HS 的反应更好。脑氧持续增加(超过 210 分钟)与良好的预后相关(P<0.023)。
HS 可增强低分级蛛网膜下腔出血患者的 CBF,并在输注后 4 小时内显著改善脑氧合。预后良好与 210 分钟后脑氧的改善有关。